Author:
Penttilä P.,Donskov F.,Rautiola J.,Peltola K.,Laukka M.,Bono P.
Reference29 articles.
1. Renal-cell carcinoma–molecular pathways and therapies;Brugarolas;N Engl J Med,2007
2. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Escudier;Ann Oncol,2016
3. Lenvatinib, everolimus, and the combination in patients with metastatic renal cell carcinoma: a randomised, phase 2, open-label, multicentre trial;Motzer;Lancet Oncol,2015
4. Nivolumab versus everolimus in advanced renal-cell carcinoma;Motzer;N. Engl J Med,2015
5. Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial;Choueiri;Lancet Oncol,2016
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献